Molecular Microscope Diagnostic System in Patients after Kidney Transplantation—First Experience.

Beliančinová, Monika; Kleinová, Patrícia; Blichová, Tímea; Vnučák, Matej; Graňák, Karol; Kajová Macháleková, Katarína; Dedinská, Ivana

Background: The diagnosis of graft rejection relies on the identification of donor-specific antibodies along with histological findings. Borderline changes are particularly challenging, representing non-rejection findings in up to 70% of cases. The analysis aimed to compare the results of histopathological conclusions with the findings from examination using a molecular microscope, which assesses gene expression (whole-genome microarray chip technology). Methods: Molecular microscope examination (MMDx) was applied to twelve patients (six men and six women) who underwent either indication or protocol graft biopsy. Results: The average age of patients was 46.6 years ± 4.2 (average follow-up from kidney transplantation was 6.1 months ± 1.2). MMDx examination was performed during indication biopsy in 11 patients and protocol biopsy in 1 patient. A total of 33% of the findings matched and 50% did not. Finally, we present a case of a patient with acute cellular rejection findings without clinical and laboratory correlation, where the use of MMDx significantly altered the treatment strategy. Conclusions: MMDx examination is suitable for complementing patients with ambiguous histological findings and a clinical picture not corresponding to biopsy results. The limitations of MMDx include cost and its inability to evaluate the potential recurrence of the underlying kidney disease in the graft.

KIDNEY transplantation; GRAFT rejection; MICROARRAY technology; MICROSCOPES

Biomedicines, 2024, Vol 12, Issue 3, p548

2227-9059

Academic Journal

10.3390/biomedicines12030548